Orcimed Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-10-2024
- Paid Up Capital ₹ 97.00 K
as on 27-10-2024
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
as on 27-10-2024
About Orcimed Life Sciences
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 97.00 K .
The company currently has active open charges totaling ₹5.00 Cr.
The Key Managerial Personnel (KMP) at Orcimed Life Sciences Private Limited India is Sumanchandra Maarisetty as CEO. Someshwar Komuravelli, Kranthi Chintala, Apurva Srigiri, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85300TG2022PTC160068
- Company No.
160068
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2022
- Date of AGM
31 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Orcimed Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumanchandra Maarisetty | CEO | 02-May-2022 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saleha Quadri  | Director | 24-Feb-2022 | Current |
| Someshwar Komuravelli | Director | 24-Feb-2022 | Current |
| Kranthi Chintala | Director | 11-Jul-2022 | Current |
| Apurva Srigiri | Director | 24-Feb-2022 | Current |
Agrella David  | Director | 01-Sep-2022 | Current |
Financial Performance of Orcimed Life Sciences.
Orcimed Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Orcimed Life Sciences?
In 2023, Orcimed Life Sciences had a public holding of 37.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
First Pharmaceuticals Private LimitedActive 2 years 6 monthsSomeshwar Komuravelli is a mutual person
- Bell Pharmaceuticals And Cosmetics Private LimitedActive 3 years 3 months
Someshwar Komuravelli is a mutual person
- Archeesh Health Care Private LimitedActive 9 years 2 months
Someshwar Komuravelli is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 08 Mar 2023 | ₹5.00 Cr | Open |
How Many Employees Work at Orcimed Life Sciences?
Orcimed Life Sciences has a workforce of 212 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orcimed Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orcimed Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
